Celecoxib concentration predicts decrease in prostaglandin E(2 )concentrations in nipple aspirate fluid from high risk women

BACKGROUND: Epidemiologic studies suggest that long term low dose celecoxib use significantly lowers breast cancer risk. We previously demonstrated that 400 mg celecoxib taken twice daily for 2 weeks lowered circulating plasma and breast nipple aspirate fluid (NAF) prostaglandin (PG)E(2 )concentrati...

Descripción completa

Detalles Bibliográficos
Autores principales: Sauter, Edward R, Qin, Wenyi, Hewett, John E, Ruhlen, Rachel L, Flynn, John T, Rottinghaus, George, Chen, Yin-Chieh
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2259321/
https://www.ncbi.nlm.nih.gov/pubmed/18267025
http://dx.doi.org/10.1186/1471-2407-8-49

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2259321/
https://www.ncbi.nlm.nih.gov/pubmed/18267025
http://dx.doi.org/10.1186/1471-2407-8-49

Ejemplares similares